ONCY

Oncolytics Biotech Inc

ONCY, USA

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.

https://oncolyticsbiotech.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
ONCY
stock
ONCY

Oncolytics Biotech Plans Jurisdiction Shift to Nevada TipRanks

Read more →
ONCY
stock
ONCY

Oncolytics Biotech (Nasdaq: ONCY) sets Jan. 15 vote on Nevada reincorporation Stock Titan

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$5.5228

Analyst Picks

Strong Buy

1

Buy

4

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

874.92

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-12,521.74 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-95.64 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

Very Low

129.93

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 1.30% of the total shares of Oncolytics Biotech Inc

1.

SEEDS INVESTOR LLC

(0.221%)

since

2025/06/30

3.

Goldman Sachs Group Inc

(0.1286%)

since

2025/06/30

4.

Geode Capital Management, LLC

(0.0661%)

since

2025/06/30

5.

Fidelity Nasdaq Composite Index

(0.0661%)

since

2025/07/31

6.

Commonwealth Equity Services Inc

(0.0643%)

since

2025/06/30

7.

Franklin Resources Inc

(0.0625%)

since

2025/06/30

8.

CIBC World Markets Inc.

(0.0596%)

since

2025/06/30

9.

Royal Bank of Canada

(0.0578%)

since

2025/06/30

10.

Head & Associates, LLC

(0.0443%)

since

2025/06/30

11.

Badgley Phelps Wealth Managers, LLC

(0.0395%)

since

2025/06/30

12.

Bank of Montreal

(0.0383%)

since

2025/06/30

13.

BMO Capital Markets Corp.

(0.0383%)

since

2025/06/30

15.

Seacrest Wealth Management, LLC

(0.0316%)

since

2025/06/30

16.

Vantage Point Financial LLC

(0.0294%)

since

2025/06/30

17.

Brave Asset Management Inc

(0.0247%)

since

2025/06/30

18.

Newman Dignan & Sheerar Inc

(0.0226%)

since

2025/06/30

19.

UBS Group AG

(0.0205%)

since

2025/06/30

20.

FINANCIAL ADVISORY CORP /UT/ /ADV

(0.0204%)

since

2025/06/30

21.

Jane Street Group LLC

(0.0201%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.14

EPS Estimate

-0.0897

EPS Difference

-0.0503

Surprise Percent

-56.0758%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.3)
GARP
Not Attractive for GARP(0.5)
Growth
Weak Growth Prospect(0.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(1.5)
Value
Overpriced(2)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.